English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A significant proportion of patients who receive implantable cardioverter-defibrillators (ICDs) have a history of atrial fibrillation (AF) at the time of the initial procedure, or new-onset AF episodes during follow-up. In a subanalysis of the PainFree SmartShock® Technology study, new-onset AF was detected in approximately 22% of patients with ICDs in the first 12 months of follow-up.1,2 Device-detected AF, even if asymptomatic, has been closely associated with an increased risk for stroke or systemic embolism.3,4 In addition, subclinical AF has been detected in almost 30% of patients with cryptogenic stroke when continuously monitored using implantable cardiac devices.5 We report the case of a patient with subclinical AF detected only after ICD analysis with integrated atrial-sensing rings. Case

international journal of arrhythmia

Early Detection of Subclinical Atrial Flutter-Fibrillation in Patients with Unexplained Palpitation Using a Novel VDD Defibrillator with Integrated Atrial-Sensing Rings